KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.
Gallina FT, Marinelli D, Melis E, Forcella D, Taje R, Buglioni S, Visca P, Torchia A, Cecere FL, Botticelli A, Santini D, Ciliberto G, Cappuzzo F, Facciolo F.
Gallina FT, et al. Among authors: taje r.
Lung Cancer. 2023 Jul;181:107254. doi: 10.1016/j.lungcan.2023.107254. Epub 2023 May 24.
Lung Cancer. 2023.
PMID: 37253296
Free article.